Tislelizumab,Sorafenib
BeiGene,Novartis
['ca,022,i', 'rationale-301', 'ca,022,1', 'sorafenib', 'tislelizumab']
 rationale-301 &gt;64 yrs tislelizumab vs sorafenib longer os in older patients but more bclc-b #wcgic2023 
Medical Oncologist; clinical and translational researcher pancreatic and hepatobiliary cancers. Views are my own 🇮🇪🇨🇦